SE9702774D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE9702774D0
SE9702774D0 SE9702774A SE9702774A SE9702774D0 SE 9702774 D0 SE9702774 D0 SE 9702774D0 SE 9702774 A SE9702774 A SE 9702774A SE 9702774 A SE9702774 A SE 9702774A SE 9702774 D0 SE9702774 D0 SE 9702774D0
Authority
SE
Sweden
Prior art keywords
pct
novel compounds
sec
date
compounds
Prior art date
Application number
SE9702774A
Other languages
English (en)
Inventor
Roger Brown
Garry Pairaudeau
Original Assignee
Astra Pharma Prod
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod
Priority to SE9702774A priority Critical patent/SE9702774D0/sv
Publication of SE9702774D0 publication Critical patent/SE9702774D0/sv
Priority to IDW20000145D priority patent/ID25856A/id
Priority to PL98338181A priority patent/PL338181A1/xx
Priority to EP98934108A priority patent/EP0998475B1/en
Priority to AT98934108T priority patent/ATE216390T1/de
Priority to KR1020007000653A priority patent/KR20010022084A/ko
Priority to HU0003826A priority patent/HUP0003826A3/hu
Priority to DE69804966T priority patent/DE69804966T2/de
Priority to US09/155,567 priority patent/US6166022A/en
Priority to TR2000/00152T priority patent/TR200000152T2/xx
Priority to CN98809157A priority patent/CN1270591A/zh
Priority to IL13411198A priority patent/IL134111A0/xx
Priority to CA002296426A priority patent/CA2296426A1/en
Priority to PCT/SE1998/001394 priority patent/WO1999005144A1/en
Priority to JP2000504140A priority patent/JP2001510843A/ja
Priority to AU83707/98A priority patent/AU8370798A/en
Priority to SK1882-99A priority patent/SK188299A3/sk
Priority to EEP200000048A priority patent/EE200000048A/xx
Priority to BR9811028-4A priority patent/BR9811028A/pt
Priority to IS5352A priority patent/IS5352A/is
Priority to NO20000313A priority patent/NO20000313L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
SE9702774A 1997-07-22 1997-07-22 Novel compounds SE9702774D0 (sv)

Priority Applications (21)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds
BR9811028-4A BR9811028A (pt) 1997-07-22 1998-07-15 Composto, composição farmacêutica, e, processos de tratamento de uma doença de agregação de plaquetas e para a preparação de um composto
US09/155,567 US6166022A (en) 1997-07-22 1998-07-15 Compounds
CN98809157A CN1270591A (zh) 1997-07-22 1998-07-15 新的化合物
EP98934108A EP0998475B1 (en) 1997-07-22 1998-07-15 Novel compounds
AT98934108T ATE216390T1 (de) 1997-07-22 1998-07-15 Neue verbindungen
KR1020007000653A KR20010022084A (ko) 1997-07-22 1998-07-15 신규한 화합물
HU0003826A HUP0003826A3 (en) 1997-07-22 1998-07-15 Novel triazolo [4,5-b] pyrimidine derivatives, process for their preparation and pharmaceutical compositions thereof
DE69804966T DE69804966T2 (de) 1997-07-22 1998-07-15 Neue verbindungen
IDW20000145D ID25856A (id) 1997-07-22 1998-07-15 Senyawa-senyawa baru
TR2000/00152T TR200000152T2 (tr) 1997-07-22 1998-07-15 Yeni bileşikler.
PL98338181A PL338181A1 (en) 1997-07-22 1998-07-15 Novel chemical compounds
IL13411198A IL134111A0 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d] pyrimidine compounds, their use anovel compounds s medicaments, compositions containing them and processes for their preparation
CA002296426A CA2296426A1 (en) 1997-07-22 1998-07-15 Novel compounds
PCT/SE1998/001394 WO1999005144A1 (en) 1997-07-22 1998-07-15 Novel compounds
JP2000504140A JP2001510843A (ja) 1997-07-22 1998-07-15 新規な化合物
AU83707/98A AU8370798A (en) 1997-07-22 1998-07-15 Novel compounds
SK1882-99A SK188299A3 (en) 1997-07-22 1998-07-15 Triazolo [4,5-d]pyrimidine compounds, preparation thereof, pharmaceutical compositions containing them and their use
EEP200000048A EE200000048A (et) 1997-07-22 1998-07-15 Uudsed ühendid
IS5352A IS5352A (is) 1997-07-22 2000-01-19 Ný efnasambönd
NO20000313A NO20000313L (no) 1997-07-22 2000-01-21 Nye forbindelser

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Publications (1)

Publication Number Publication Date
SE9702774D0 true SE9702774D0 (sv) 1997-07-22

Family

ID=20407805

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9702774A SE9702774D0 (sv) 1997-07-22 1997-07-22 Novel compounds

Country Status (21)

Country Link
US (1) US6166022A (sv)
EP (1) EP0998475B1 (sv)
JP (1) JP2001510843A (sv)
KR (1) KR20010022084A (sv)
CN (1) CN1270591A (sv)
AT (1) ATE216390T1 (sv)
AU (1) AU8370798A (sv)
BR (1) BR9811028A (sv)
CA (1) CA2296426A1 (sv)
DE (1) DE69804966T2 (sv)
EE (1) EE200000048A (sv)
HU (1) HUP0003826A3 (sv)
ID (1) ID25856A (sv)
IL (1) IL134111A0 (sv)
IS (1) IS5352A (sv)
NO (1) NO20000313L (sv)
PL (1) PL338181A1 (sv)
SE (1) SE9702774D0 (sv)
SK (1) SK188299A3 (sv)
TR (1) TR200000152T2 (sv)
WO (1) WO1999005144A1 (sv)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9702773D0 (sv) * 1997-07-22 1997-07-22 Astra Pharma Prod Novel compounds
DE69905451T2 (de) * 1998-02-17 2003-11-20 Astrazeneca Uk Ltd Neue triazolo(4,5d) pyrimidinverbindungen
EP1210324B1 (en) 1999-09-09 2004-03-31 Chirotech Technology Limited Substituted cyclopentenes, their preparation and their use for chiral scaffolds
SE9904129D0 (sv) * 1999-11-15 1999-11-15 Astra Pharma Prod Novel compounds
US7018985B1 (en) 2000-08-21 2006-03-28 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7115585B2 (en) * 2000-08-21 2006-10-03 Inspire Pharmaceuticals, Inc. Compositions for treating epithelial and retinal tissue diseases
US6897201B2 (en) 2000-08-21 2005-05-24 Inspire Pharmaceuticals, Inc. Compositions and methods for the treatment of glaucoma or ocular hypertension
US7132408B2 (en) * 2000-08-21 2006-11-07 Inspire Pharmaceuticals, Inc. Composition and method for inhibiting platelet aggregation
US7452870B2 (en) * 2000-08-21 2008-11-18 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with P2Y12 receptor antagonist compound
AR039558A1 (es) * 2000-08-21 2005-02-23 Inspire Pharmaceuticals Inc Composiciones y metodo para el tratamiento de glaucoma o hipertension ocular
US7435724B2 (en) * 2002-02-27 2008-10-14 Inspire Pharmaceutical, Inc. Degradation-resistant mononucleoside phosphate compounds
WO2005035520A1 (en) 2003-10-03 2005-04-21 Portola Pharmaceuticals, Inc. Substituted isoquinolinones
JP2007507551A (ja) 2003-10-03 2007-03-29 ポートラ ファーマシューティカルズ， インコーポレイテッド ２，４−ジオキソ−３−キナゾリニルアリールスルホニル尿素
US7335648B2 (en) 2003-10-21 2008-02-26 Inspire Pharmaceuticals, Inc. Non-nucleotide composition and method for inhibiting platelet aggregation
US7749981B2 (en) 2003-10-21 2010-07-06 Inspire Pharmaceuticals, Inc. Drug-eluting stents coated with non-nucleotide P2Y12 receptor antagonist compound
US7504497B2 (en) 2003-10-21 2009-03-17 Inspire Pharmaceuticals, Inc. Orally bioavailable compounds and methods for inhibiting platelet aggregation
US7368438B2 (en) 2003-10-21 2008-05-06 Inspire Pharmaceuticals, Inc. Non-nucleotide compositions and method for inhibiting platelet aggregation
EP1812429A4 (en) 2004-09-29 2010-07-21 Portola Pharm Inc SUBSTITUTED 2H-1,3-BENZOXAZIN-4 (3H) -ONE
US7932376B2 (en) 2005-05-05 2011-04-26 Inspire Pharmaceuticals, Inc. Pyrimidine-based non-nucleotide composition and method for inhibiting platelet aggregation
WO2007020935A1 (ja) * 2005-08-17 2007-02-22 Ono Pharmaceutical Co., Ltd. Ｐ２ｙ１２受容体および／またはｐ２ｙ１４受容体ブロッカーを含有してなる疼痛治療剤
US20070208045A1 (en) 2005-11-03 2007-09-06 Portola Pharmaceuticals, Inc. Substituted-(quinazolinyl)phenyl thiophenyl-sulfonylureas, methods for making and intermediates thereof
US7566722B2 (en) * 2006-10-31 2009-07-28 Janssen Pharmaceutica, N.V. Triazolopyrimidine derivatives as ADP P2Y12 receptor antagonists
US9725479B2 (en) 2010-04-22 2017-08-08 Ionis Pharmaceuticals, Inc. 5′-end derivatives
EP2576553A4 (en) * 2010-05-27 2013-11-20 Reddys Lab Ltd Dr EXTREMELY SELECTIVE ASYMMETRIC HYDROFORMYLATION OF (+) OR (-) - LACTAM (1S, 4R) - OR (1R, 4S) -2-AZABICYCLO [2.2.1] HEPT-5-EN-3-ONE
US9458244B2 (en) 2012-12-28 2016-10-04 Abbvie Inc. Single chain multivalent binding protein compositions and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4742064A (en) * 1985-09-10 1988-05-03 Regents Of The University Of Minnesota Antiviral carbocyclic analogs of xylofuranosylpurines
GB8826205D0 (en) * 1988-11-09 1988-12-14 Wellcome Found Heterocyclic compounds
WO1994018215A1 (en) * 1993-02-03 1994-08-18 Gensia, Inc. Adenosine kinase inhibitors comprising lyxofuranosyl derivatives
EP0840740B1 (en) * 1995-07-11 2002-05-02 AstraZeneca AB New inhibitors of platelet aggregation

Also Published As

Publication number Publication date
WO1999005144A1 (en) 1999-02-04
EE200000048A (et) 2000-10-16
NO20000313L (no) 2000-03-22
IL134111A0 (en) 2001-04-30
CN1270591A (zh) 2000-10-18
IS5352A (is) 2000-01-19
TR200000152T2 (tr) 2000-07-21
JP2001510843A (ja) 2001-08-07
ID25856A (id) 2000-11-09
DE69804966T2 (de) 2002-11-07
EP0998475A1 (en) 2000-05-10
PL338181A1 (en) 2000-10-09
KR20010022084A (ko) 2001-03-15
EP0998475B1 (en) 2002-04-17
CA2296426A1 (en) 1999-02-04
ATE216390T1 (de) 2002-05-15
HUP0003826A3 (en) 2001-11-28
HUP0003826A2 (hu) 2001-04-28
SK188299A3 (en) 2000-08-14
US6166022A (en) 2000-12-26
AU8370798A (en) 1999-02-16
BR9811028A (pt) 2000-08-01
DE69804966D1 (de) 2002-05-23
NO20000313D0 (no) 2000-01-21

Similar Documents

Publication Publication Date Title
SE9702774D0 (sv) Novel compounds
SE9702772D0 (sv) Novel compounds
TR200000197T2 (tr) Yeni bileşimler
YU45403A (sh) Novi 1,2-difenil-azetidinoni, postupak za njihovu proizvodnju, lekovi koji sadrže ova jedinjenja i njihova primena za lečenje poremećaja u metabolizmu lipida
GEP20084329B (en) 5,7-diaminopyrazolo [4,3-d] pyrimidines useful in the treatment of hypertension
YU40300A (sh) Aril fuzirana azapoliciklična jedinjenja
BG101110A (en) Substituted pyrimidine compounds and their application
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
SE9702564D0 (sv) New compounds
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
TR200002380T2 (tr) Yeni triazolo (4,5-d) pirimidin bileşikleri
SE9702563D0 (sv) Compounds
YU64400A (sh) Aril fuzirana azapoliciklična jedinjenja
AP2001002188A0 (en) 5HT1 antagonists for antidepressant therapy.
NO970473L (no) N-substituerte 3-azabicyklo (3.2.0)heptanderivater egnet som neuroleptika
SE9802574D0 (sv) Novel compounds
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
BG101328A (en) New derivatives of imidazoloquinaxalon with heterocyclic substituents, their preparation and use
SE0004099D0 (sv) Novel compounds
PT1025101E (pt) Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central
MY133140A (en) N-substituted azabicycloheptane derivatives, their preparation and use
MY136138A (en) Hexacyclic compounds